| Pivot Physical Therapy Of Maryland | |
|
141 Thomas Johnson Dr, Ste 180, Frederick, MD 21702-4502 | |
| (301) 620-7478 | |
| (301) 620-7479 |
| Full Name | Pivot Physical Therapy Of Maryland |
|---|---|
| Type | Facility |
| Speciality | Physical Therapist |
| Location | 141 Thomas Johnson Dr, Frederick, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003272410 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Pivot Physical Therapy Of Maryland 501 Fairmount Ave, Ste 302, Towson, MD 21286-5457 Ph: (410) 927-8768 | Pivot Physical Therapy Of Maryland 141 Thomas Johnson Dr, Ste 180, Frederick, MD 21702-4502 Ph: (301) 620-7478 |
News Archive
Global Health Partner has started up a business for the treatment of obesity in Prague, and the first obesity operations have now been performed.
Agreement by governments, by the end of 2012, on a set of ambitious global targets to curb the growing scourge of non-communicable diseases (NCDs), which includes cardiovascular disease (CVD; heart disease and stroke), is critical to avoiding the millions of premature deaths worldwide. This, according to a new paper published by the Global Cardiovascular Disease Taskforce a group of eminent experts who represent five leading heart-health organizations.
A new paradigm to explain glaucoma is rapidly emerging, and it is generating brain-based treatment advances that may ultimately vanquish the disease known as the "sneak thief of sight." A review now available in Ophthalmology, the journal of the American Academy of Ophthalmology, reports that some top researchers no longer think of glaucoma solely as an eye disease.
Over a quarter of UK patients treated for growth hormone-producing tumours do not achieve 'safe' growth hormone levels, according to a 30 year UK multi-centre study of clinical management of the rare disease acromegaly. The findings by the Society for Endocrinology UK Acromegaly Register, published in the November issue of Clinical Endocrinology, show that drugs to control acromegaly often fail to bring the disease completely under control in routine clinical practice.
The U.S. Food and Drug Administration today approved Zinbryta (daclizumab) for the treatment of adults with relapsing forms of multiple sclerosis (MS). Zinbryta is a long-acting injection that is self- administered by the patient monthly.
› Verified 4 days ago
Janine Velasquez Bautista, Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 7819 Rocky Springs Rd, Frederick, MD 21702 Phone: 877-407-3422 Fax: 877-407-4329 | |
James R. Bucklin Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 5300 Westview Dr Ste 108, Frederick, MD 21703 Phone: 301-732-4754 | |
Erin Roosa, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 141 Thomas Johnson Dr, Ste 180, Frederick, MD 21702 Phone: 301-620-7478 | |
Mr. Thomas Michael Stief, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 626 Trail Ave, Frederick, MD 21701 Phone: 301-662-1997 Fax: 301-668-2202 | |
Ashley Wertman, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 5301 Buckeystown Pike, Frederick, MD 21704 Phone: 240-215-4668 | |
Carolyn Sherwood, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1562 Opossumtown Pike, Frederick, MD 21702 Phone: 240-566-3400 Fax: 240-566-3125 |